alarm
period
emerg
viral
pneumonia
infect
due
coronaviru
case
zoonos
pass
barrier
speci
infect
human
legitim
concern
intern
commun
due
fact
new
identifi
coronaviru
name
previous
call
quit
high
mortal
rate
around
strong
abil
spread
estim
reproduct
number
higher
even
though
countri
utmost
stop
pandem
reliabl
solut
tackl
infect
rapid
develop
vaccin
purpos
mean
bioinformat
appli
context
reversevaccinolog
paradigm
fundament
help
select
promis
peptid
abl
trigger
effect
immun
respons
short
report
use
concept
nullom
introduc
distanc
human
self
provid
list
peptid
could
deserv
experiment
investig
view
potenti
vaccin
coronavirus
belong
famili
coronavirida
order
nidoviral
human
respons
mild
respiratori
infect
like
cold
also
much
seriou
diseas
like
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
mer
recent
decemb
alarm
emerg
citi
wuhan
china
new
viral
pneumonia
infect
due
novel
coronaviru
fall
within
genu
betacoronaviru
trace
seafood
wholesal
market
name
preliminari
analysi
reveal
differ
sequenc
genom
strain
exhibit
sequenc
ident
close
relat
ident
batderiv
sarslik
coronavirus
distant
human
sarscov
human
merscov
lu
et
al
accord
current
statist
new
coronaviru
seem
less
lethal
previou
sar
mer
outbreak
percentag
death
far
around
spread
fastli
coupl
month
epidem
alreadi
infect
kill
patient
previou
coronaviru
infect
sar
mer
middl
februari
dead
seventi
thousand
infect
china
view
rapid
develop
vaccin
focal
issu
avoid
pandem
accord
new
paradigm
revers
vaccinolog
rappuoli
identif
epitop
abl
trigger
immun
respons
pathogen
fundament
step
develop
effect
new
vaccin
work
appli
origin
comput
methodolog
togeth
reliabl
effect
bioinformat
tool
order
select
promis
viral
peptid
abl
trigger
effect
immun
respons
particular
core
propos
methodolog
base
select
viral
peptid
three
mutat
step
far
human
self
term
select
high
order
nullom
ie
viral
peptid
absent
human
simpl
nullom
hampikian
andersen
peptid
obtain
mutat
three
aminoacid
still
absent
highlight
santoni
shown
high
order
nullom
higher
probabl
bind
hla
expect
moreov
opinion
identif
farthestfromhuman
peptid
could
interest
view
vaccin
design
crossreact
reason
sinc
expect
averag
high
number
potenti
j
u
r
n
l
p
r
e
p
r
f
journal
preproof
antibodi
abl
recogn
avoid
autoimmun
risk
low
similar
human
self
peptid
name
third
order
nullom
accord
vergni
santoni
w
specifi
follow
process
order
select
one
highest
likelihood
expos
cell
surfac
accord
three
select
step
probabl
product
proteasom
cleavag
ii
probabl
carri
taptransport
complex
iii
probabl
strongli
bind
least
one
hla
among
consid
studi
final
identifi
minim
set
peptid
interest
could
deserv
experiment
investig
previou
studi
involv
nullom
propos
design
novel
therapeut
strategi
silva
et
al
alilech
hampikian
use
high
order
nullom
instead
simpl
nullom
certainli
repres
step
forward
context
homo
sapien
proteom
download
ensembl
site
http
ftpensemblorgpubcurrentfastahomosapienspep
taken
refer
ad
hoc
script
design
order
extract
possibl
sequenc
human
proteom
worth
note
work
contigu
peptid
size
consid
choic
significantli
affect
result
work
sinc
largest
part
peptid
present
cell
surfac
mhc
class
complex
contigu
sequenc
therefor
hereaft
term
peptid
indic
contigu
peptid
without
ambigu
use
h
c
v
indic
human
peptid
respect
given
two
peptid
equal
human
obtain
p
mutat
number
aminocid
smaller
accord
distanc
defin
differ
disjoint
subset
c
v
start
common
class
c
ie
subset
c
v
common
h
first
class
absent
peptid
w
contain
peptid
present
human
chang
least
one
human
peptid
singl
mutat
step
gener
th
class
absent
peptid
w
follow
peptid
belong
class
w
need
mutat
step
less
order
chang
least
one
human
peptid
follow
also
refer
softwar
netmhc
version
lundegaard
et
al
use
predict
interact
peptid
mhc
class
complex
term
bind
probabl
score
take
account
differ
hla
class
class
b
class
c
class
e
accord
netmhc
softwar
peptid
predict
strongli
bind
sb
given
hla
relat
interact
score
j
u
r
n
l
p
r
e
p
r
f
journal
preproof
smaller
equal
predict
weak
bind
wb
score
fall
rang
softwar
netctl
version
larsen
et
al
use
predict
proteasom
cleavag
probabl
indic
cle
transport
score
relat
transport
associ
antigen
process
indic
tap
total
number
differ
occur
contigu
substr
human
proteom
total
number
uniqu
contigu
tabl
show
partit
peptid
respect
human
self
depend
distanc
human
peptid
report
section
tabl
partit
wuhan
coronaviru
class
c
follow
focu
peptid
belong
class
farthest
human
self
peptid
share
far
avail
strain
two
remain
miss
one
strain
imrlwlcwk
mrlwlcwkc
miss
strain
surpris
current
avail
strain
exhibit
sequenc
ident
worth
note
peptid
c
v
turn
word
four
step
mutat
suffici
obtain
everi
peptid
c
v
least
one
peptid
h
start
peptid
set
appli
select
step
accord
probabl
product
proteasom
cleavag
propens
transport
cell
surfac
tap
complex
probabl
score
bind
mhc
class
complex
peptid
show
least
one
predict
hla
strong
bind
report
tabl
j
u
r
n
l
p
r
e
p
r
f
journal
preproof
togeth
follow
featur
number
hla
peptid
strongli
weakli
respect
orf
peptid
occur
also
mention
nsp
nonstructur
protein
accord
chan
et
al
posit
peptid
respect
correspond
orf
proteasom
cleavag
taptransport
predict
score
tabl
list
select
peptid
second
third
column
report
number
hla
peptid
strongli
weakli
respect
bind
fourth
column
orf
peptid
occur
report
fifth
column
indic
posit
peptid
correspond
orf
proteasom
cleavag
taptransport
predict
score
report
sixth
seventh
column
respect
peptid
yyhknnksw
whose
aminoacid
result
belong
solventaccess
surfac
area
spike
protein
label
j
u
r
n
l
p
r
e
p
r
f
none
occur
mer
human
sar
conclus
technic
note
provid
list
peptid
potenti
target
immun
system
could
experiment
test
order
valid
immunogen
peptid
select
farthest
mutat
term
human
self
belief
confirm
previou
bioinformat
analysi
santoni
higher
j
u
r
n
l
p
r
e
p
r
f
journal
preproof
distanc
human
self
higher
probabl
bind
hla
moreov
select
peptid
also
chosen
high
probabl
cleav
proteasom
tap
transport
cell
surfac
interestingli
one
select
peptid
found
locat
solventaccess
surfac
area
spike
protein
